首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1622471

支架市場規模、佔有率、成長分析、按產品、按材料、按最終用戶、按地區 - 行業預測，2025-2032 年

Stents Market Size, Share, Growth Analysis, By Product (Vascular, Non-Vascular Stents), By Material (Metallic Stents, Non-Metallic Stents), By End User, By Region - Industry Forecast 2025-2032

出版日期: 2024年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023年支架市場規模為93億美元，從2024年的96.1億美元成長到2032年的125億美元，在預測期間（2025-2032年）年複合成長率為3.3%。

據 CDC 稱，由於冠狀動脈疾病盛行率上升，全球支架市場正在顯著成長，該疾病導致 2019 年約 360,900 人死亡。這種快速成長的推動因素包括支架設計的技術進步、私人和政府對醫療保健發展的投資增加以及對藥物釋放型支架的需求不斷增加。支架是維持阻塞動脈血流的重要醫療設備，不僅用於預防心血管疾病，也用於預防主動脈和大腦等重要部位的動脈瘤。一個顯著的例子是中國醫藥於2021年8月在歐洲推出HT Supreme藥物釋放型支架，凸顯了該行業的持續創新和對患者需求的回應能力。

市場概況
血管
- 冠狀動脈支架
- 周邊設備支架
- 髂動脈支架
- 股動脈支架
- 頸動脈支架
- 腎動脈支架
- 其他周邊設備支架
- 神經血管支架
- 顱內支架
- 分流器
非血管支架
- 胃腸支架
- 膽道
- 十二指腸
- 冒號
- 胰臟
- 食道支架
- 肺（氣道）支架
- 矽膠氣道
- 金屬氣道
- 泌尿系統支架
- 其他

支架市場規模：依材料分類

市場概況
金屬支架
非金屬支架

支架市場規模：依最終用戶分類

市場概況
醫院
專科診所
門診手術中心
其他

支架市場規模

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2022-2024）

主要企業簡介

Boston Scientific
Medtronic
Abbott Laboratories
Terumo Corporation
Johnson & Johnson
B. Braun Melsungen AG
BIOTRONIK SE & Co. KG
Cook Medical
MicroPort Scientific Corporation
Sahajanand Medical Technologies
Alvimedica
Biosensors International
Lepu Medical Technology
Meril Life Sciences
Balton Sp. z oo
Translumina Therapeutics
Vascular Concepts
Relisys Medical Devices
Endocor GmbH
Hexacath

結論和建議

簡介目錄

Product Code: SQMIG35A2607

Stents Market size was valued at USD 9.3 Billion in 2023 and is poised to grow from USD 9.61 Billion in 2024 to USD 12.5 Billion by 2032, growing at a CAGR of 3.3% during the forecast period (2025-2032).

The global stents market is witnessing significant growth driven by the rising prevalence of coronary artery disease, which led to approximately 360,900 deaths in 2019, according to the CDC. This surge is propelled by technological advancements in stent design, heightened investment from both private and government sources into healthcare development, and an escalating demand for drug-eluting stents. Stents, essential medical devices that maintain blood flow in blocked arteries, are increasingly being utilized not only for cardiovascular diseases but also for preventing aneurysms in critical areas like the aorta and brain. A notable example includes the European launch of the HT Supreme Drug-eluting stent by Sinomed in August 2021, highlighting the industry's continuous innovation and response to patient needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Stents Market Segmental Analysis

Global Stents Market is segmented by product, material, end user and region. Based on product, the market is segmented into vascular and non-vascular stents. Based on material, the market is segmented into metallic stents and non-metallic stents. Based on end user, the market is segmented into hospitals, specialty clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Stents Market

The stent market is significantly driven by the increasing global incidence of cardiovascular diseases (CVDs), which is anticipated to enhance market growth in the coming years. The rise in chronic disease cases is leading to greater demand for procedures such as percutaneous coronary interventions and peripheral vascular surgeries. The World Health Organization (WHO) reports that cardiovascular diseases result in approximately 17.9 million deaths annually, representing around 32% of all global fatalities. As the number of individuals affected by cardiovascular conditions continues to grow, it will inevitably heighten the need for stents, thereby propelling market demand.

Restraints in the Stents Market

One significant restraint on the stents market is the rigorous regulatory environment that hinders its growth potential. Various regulatory agencies, including the FDA, enforce stringent guidelines and requirements for the safe and effective use of stents. The FDA's thorough evaluation process necessitates a careful review of existing literature and pre-clinical animal studies prior to granting approval. This process is often resource-intensive, demanding considerable time and financial investment, particularly as coronary stents are classified as category III devices. Additionally, the classification of stents as medium to high-risk medical devices subjects them to stringent regulatory compliance, ultimately dampening market demand due to the complexity and costs associated with obtaining necessary approvals.

Market Trends of the Stents Market

The stents market is witnessing significant growth driven by continuous innovations and refinements in product design. Key advancements focus on optimizing stent features, such as reducing strut thickness, enhancing deliverability in complex vascular anatomies, and introducing a variety of lengths and diameters. Recent breakthroughs, like the FDA-approved Xience Sierra in 2018, emphasize enhanced flexibility and smaller profiles for improved performance during percutaneous coronary interventions (PCI). These developments aim to enhance patient outcomes and reduce procedural complications, thereby fueling market expansion. As healthcare providers increasingly adopt these advanced stent technologies, the market is poised for robust growth in the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Trade Analysis

Global Stents Market Size by Product & CAGR (2025-2032)

Market Overview
Vascular
- Coronary Stents
- Peripheral Stents
- Iliac Artery Stents
- Femoral Artery Stents
- Carotid Artery Stents
- Renal Artery Stents
- Other Peripheral Stents
- Neurovascular Stents
- Intracranial Stents
- Flow Diverters
Non-Vascular Stents
- Gastrointestinal Stents
- Biliary
- Duodenal
- Colonic
- Pancreatic
- Esophageal Stents
- Pulmonary (Airway) Stents
- Silicone Airway
- Metallic Airway
- Urological Stents
- Others

Global Stents Market Size by Material & CAGR (2025-2032)

Market Overview
Metallic Stents
Non-Metallic Stents

Global Stents Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Specialty Clinics
Ambulatory Surgery Centers
Others

Global Stents Market Size & CAGR (2025-2032)

North America (Product, Material, End User)
- US
- Canada
Europe (Product, Material, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Material, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Material, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Material, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sahajanand Medical Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alvimedica
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensors International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balton Sp. z o.o.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Translumina Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascular Concepts
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Relisys Medical Devices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endocor GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hexacath
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments